Patents by Inventor Richard Mazess

Richard Mazess has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070043005
    Abstract: The present invention provides a method of inhibiting the hyperproliferative cellular activity of neoplasms and other hyperproliferative diseases with an active vitamin D compound utilizing a high dose, episodic treatment protocol.
    Type: Application
    Filed: May 11, 2006
    Publication date: February 22, 2007
    Applicant: Genzyme Corporation
    Inventor: Richard Mazess
  • Publication number: 20060183722
    Abstract: The invention relates to pharmaceutical formulations of lipophilic therapeutic agents in which such agents are solubilized in largely aqueous vehicles, and processes for preparing and using the same.
    Type: Application
    Filed: April 20, 2006
    Publication date: August 17, 2006
    Applicant: Genzyme Corporation
    Inventors: Richard Mazess, Jeffrey Driscoll, Creighton Goldensoph, Leon LeVan
  • Publication number: 20060034851
    Abstract: The present invention is directed to a conjugate which includes at least one vitamin D moiety thereof and at least one targeting molecule moiety to pharmaceutical compositions of the conjugate, and to methods for using the conjugate for target-specific delivery of vitamin D or analogs thereof to tissues in need thereof. When a particularly preferred form is administered to a patient, the targeting molecule component of the conjugate of this invention seeks out and binds to a tissue of interest, such as bone or tumor tissue, where the vitamin D has a therapeutic effect.
    Type: Application
    Filed: August 25, 2005
    Publication date: February 16, 2006
    Applicant: Genzyme Corporation
    Inventors: Richard Mazess, Charles Bishop
  • Publication number: 20050148558
    Abstract: The invention provides a stabilized 1?-hydroxyvitamin D (“SHVD”) which is particularly well suited for pharmaceutical formulations.
    Type: Application
    Filed: February 24, 2005
    Publication date: July 7, 2005
    Applicant: Bone Care International, Inc.
    Inventors: Joyce Knutson, Richard Mazess, Charles Bishop